Tag: Biogen

Biogen has set the wholesale acquisition cost for a single dose of Tofersen, also known as Qalsody, at $14,230. This steep price makes understanding **how much does a Tofersen injection cost** a critical concern for patients and their families seeking treatment for SOD1-ALS.

More than 25 brand-name and generic medications are currently approved for managing multiple sclerosis, with a diverse field of pharmaceutical companies dedicated to developing and manufacturing these vital treatments. This complex landscape is dominated by several major players who make MS drugs, alongside a growing number of smaller biotech firms.

According to manufacturer Biogen, the wholesale acquisition cost for a single vial of Qalsody (tofersen) is $14,230. This puts the first-year list price for tofersen at nearly $200,000, creating significant discussion around the cost of this rare disease treatment.